Connection

Gunnar Gislason to Administration, Oral

Back to Details
This is a "connection" page, showing publications Gunnar Gislason has written about Administration, Oral.
Gunnar Gislason
Connection Strength
0.251
Administration, Oral
  1. Major Bleeding Complications and Persistence With Oral Anticoagulation in Non-Valvular Atrial Fibrillation: Contemporary Findings in Real-Life Danish Patients. J Am Heart Assoc. 2017 02 14; 6(2).
    View in: PubMed
    Score: 0.097
  2. Pregnancy complications, treatment characteristics and birth outcomes in women with atopic dermatitis in Denmark. J Eur Acad Dermatol Venereol. 2019 Mar; 33(3):577-587.
    View in: PubMed
    Score: 0.027
  3. Shifting to a non-vitamin K antagonist oral anticoagulation agent from vitamin K antagonist in atrial fibrillation. Europace. 2018 06 01; 20(6):e78-e86.
    View in: PubMed
    Score: 0.027
  4. Resumption of oral anticoagulation following traumatic injury and risk of stroke and bleeding in patients with atrial fibrillation: a nationwide cohort study. Eur Heart J. 2018 05 14; 39(19):1698-1705a.
    View in: PubMed
    Score: 0.026
  5. Use of oral anticoagulants in combination with antiplatelet(s) in atrial fibrillation. Heart. 2018 06; 104(11):912-920.
    View in: PubMed
    Score: 0.025
  6. Increased use of oral anticoagulants in patients with atrial fibrillation: temporal trends from 2005 to 2015 in Denmark. Eur Heart J. 2017 Mar 21; 38(12):899-906.
    View in: PubMed
    Score: 0.024
  7. Comparative safety and effectiveness of rivaroxaban versus VKAs in patients with venous thromboembolism. A Danish nationwide registry-based study. Thromb Haemost. 2017 06 02; 117(6):1182-1191.
    View in: PubMed
    Score: 0.024
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.